by Jordana Choucair | Dec 8, 2022 | M&A
LHC Group and UnitedHealth Group disclosed to the Securities and Exchange Commission that their $5.4 billion proposed merger won’t consummate as planned by the end year. According to the filing, the agreement was extended until March 28, 2023 as the two...
by Jordana Choucair | Dec 8, 2022 | Providers
Hospitals in some non-Medicaid expansion states are pitching expansion to help solve the rural health crisis. According to state projections, expansion could generate $1 billion a year and create more than 11,000 jobs in Mississippi, $32 million in savings of over the...
by Jordana Choucair | Dec 8, 2022 | Public Health/Prevention
Centers for Disease Control and Prevention (CDC) Director Rochelle Walensky said the agency needs more COVID-19 funding and authority from Congress to improve data reporting processes from states and providers. Her call for more support from Congress comes as the...
by Jordana Choucair | Dec 8, 2022 | Public Health/Prevention
The Covax initiative, which facilitates global COVID-19 vaccine sharing, could come to an end as soon as next year, per an internal board document obtained by The Washington Post. Experts said the move may be a sign that global public health institutions view COVID-19...
by Jordana Choucair | Dec 2, 2022 | Life Sciences
Pfizer Inc. plans to invest more than $2.5 billion in manufacturing plants in Belgium and Ireland. The company hopes that developing new products will offset losses from expiring patents and declining COVID-19 vaccine sales. (Article here)
by Jordana Choucair | Dec 2, 2022 | Life Sciences
Merck & Co. could maintain patents for its best-selling drug Keytruda by patenting an injectable form of the medicine, which it’s currently testing in clinical trials. Certain patents for Keytruda are up in 2028, when copies of the drug could hit the market....
Recent Comments